This article aims to explore the relationship between MDA and the low disease activity cutoffs of the PASDAS and the CPDAI. Cut-offs for very low disease activity were developed.
This study aimed to validate a cutoff value of PASDAS that defines minimal disease activity (MDA) state, as well as to validate previously defined PASDAS cutoffs for low and high disease activity.
This study aims to compare the performance of the PASDAS, the AMDF, the CPDAI, and the DAPSA in the GO-REVEAL data set.
GRAPPA and OMERACT met to further the develop a consensus among physicians and patients regarding composite disease activity measures and targets in psoriatic arthritis (PsA).
https://onlinelibrary.wiley.com/doi/full/10.1002/art.40391